iifl-logo-icon 1

Max Healthcare Institute Ltd Board Meeting

913.8
(-0.44%)
Jul 5, 2024|12:00:00 AM

Max Healthcare CORPORATE ACTIONS

08/07/2023calendar-icon
07/07/2024calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting22 May 202416 May 2024
Max Healthcare Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2024 inter alia to consider and approve Financial Results and recommend Final Dividend if any Outcome of Board meeting held on May 22, 2024 (As Per BSE Announcement Dated on 22.05.2024)
Board Meeting31 Jan 202419 Jan 2024
Max Healthcare Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2024 inter alia to consider and approve unaudited standalone and consolidated financial results of the Company for the quarter and nine months ended December 31 2023. Standalone and Consolidated Financial Results for quarter and nine months ended December 31, 2023 Outcome of Board Meeting held on January 31, 2024 (As Per BSE Announcement dated on 31.01.2024)
Board Meeting6 Nov 202327 Oct 2023
Max Healthcare Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2023 inter alia to consider and approve unaudited standalone and consolidated financial results of the Company for the quarter and half year ended September 30 2023 Outcome of Board Meeting held on November 6, 2023 Standalone and Consolidated financial results for quarter and half year ended September 30, 2023 (As per BSE Announcement Dated on 06/11/2023)
Board Meeting7 Aug 202328 Jul 2023
Max Healthcare Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2023 inter alia to consider and approve unaudited standalone and consolidated financial results of the Company for the quarter ended June 30 2023 MAX HEALTHCARE INSTITUTE LIMITED has informed BSE about Board Meeting to be held on 07 Aug 2023 to consider financial statements for the period ended June 2023. Financial results. Standalone and Consolidated Financial results for Quarter ended June 30 2023. Board Meeting Outcome for meeting held on August 7, 2023 (As Per BSE Announcement Dated on 07.08.2023)

Max Healthcare: Related News

No record found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.